A study by Stanisavljevic et al. demonstrated that expression of CXCL12 and relative of the CXCL12–CXCR4 axis are independent predictors of 5-year disease-free survival (DFS) in TNM stage III colon cancer [98]. Here, CXCL12 is linked to colonic neoplasm.